Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle | Contract Pharma
Breaking News, Promotions & Moves

Kendle

Jeffrey M. Zucker has been appointed senior director and global head of patient recruitment at Kendle.

Jeffrey M. Zucker has been appointed senior director and global head of patient recruitment at Kendle. Mr. Zucker will provide global leadership for the development and implementation of innovative strategies to accelerate patient recruitment, improve retention and support the timely and efficient delivery of Phase I-IV clinical development programs for the company’s biopharmaceutical customers.

“Patient recruitment is at the core of the clinical development process,” said Stephen Cutler, Ph.D., senior vice president and chief operating officer. “Finding the right patients for the right studies and keeping them engaged throughout is essential to producing sound clinical research. Jeff’s extensive management experience across many facets of the biopharmaceutical industry will be a great asset for our customers and we are pleased to welcome him to Kendle.”

Mr. Zucker has 15 years of clinical development and management experience. Most recently, he led global trial optimization efforts for Merck & Co. He also has served as director of inpatient operations at CRI Worldwide and as founder and president of Applied Research Trials. Additionally, he held leadership positions for Eli Lilly, Princeton Biomedical Research and multiple clinical investigative sites.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters